On Tuesday, Establishment Labs Hldgs got an upgrade to its Relative Strength (RS) Rating, from 67 to 77.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best stocks tend to have an RS Rating north of 80 as they begin their biggest climbs. See if Establishment Labs Hldgs can continue to rebound and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
While the stock is not near a proper entry right now, see if it goes on to form and break out from a proper chart pattern.
Establishment Labs Hldgs showed 0% EPS growth last quarter, while sales growth came in at 4%.
Establishment Labs Hldgs earns the No. 65 rank among its peers in the Medical-Products industry group. Globus Medical, Penumbra and Insulet are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
